Effect of intravenous iron supplementation in two-stage revision surgery of hip and knee arthroplasty
Recruiting
- Conditions
- D62Acute posthaemorrhagic anaemia
- Registration Number
- DRKS00026116
- Lead Sponsor
- Orthopädische Klinik König-Ludwig-Haus
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Group 1 (intervention): - hip or knee prosthesis explanted and replaced by spacer, - scheduled for re-implantation, - intravenous iron administration during the interval after explantation and before re-implantation, - no clinical signs of persistent infection at the time point of iron administration
Group 2 (historic control): - prosthesis explanted and replaced by spacer, - scheduled for re-implantation, matched pair for group 1 according to type of joint, age, ASA score, gender and severeness of anaemia at the time point of iron supplementation
Exclusion Criteria
Group 1: none.
Group 2: intravenous iron administration,
- persistent clinical signs of infection at the matched patient's time point of iron administration
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Transfusion of allogenic red blood cells during or shortly after the re-implantation of the prosthesis.
- Secondary Outcome Measures
Name Time Method Occurrence of adverse events after iron administration; mobility and length of stay after second surgery.